While patients with triple-negative and HER2-positive breast cancer tend to have early recurrences, luminal breast cancer is known to recur even more than 10 years after surgery, and late recurrences are more common than for the other two types of breast cancer (6). This evidence concerns the gene ERBB2 and breast cancer.